Using the EpCAM-binding DARPins Ec1 and Ac2, we observed a high activity and specificity in 2D and 3D in vitro ovarian cancer models, a high specificity in patient material and an effective tumor homing in vivo, illustrating the potential of EpCAM-targeted PDT using DARPins. This evidence concerns the gene EPCAM and neoplasm.